CM Hospitalar (VVEO3) Q3 2024 earnings summary

Executive summary

• Net revenue in 3Q24 reached R$2.95 billion, up 3.8% year-over-year, with 9M24 revenue at R$8.67 billion, a 5.9% increase from 9M23.

• Strategic projects and integration efforts since mid-2023, including ERP reduction, WMS implementation, and rebranding, improved operational quality, working capital, and cash generation.

• Focus shifted from rapid expansion to operational excellence, with key projects in supply chain, cost reduction, order-to-cash cycle, and backoffice consolidation showing tangible improvements.

• Adjusted EBITDA dropped 41.5% in 3Q24 to R$146.8 million (5.0% margin), mainly due to non-recurring provisions and higher expenses.

• Free cash flow generation reached R$506.9 million in 3Q24, driven by working capital improvements and receivables sales.

Financial highlights

• Gross profit was R$391.9 million in 3Q24, with a gross margin of 13.3%, down 8.2% year-over-year due to mix effects and market margin pressure.

• Adjusted net loss was R$55.8 million in 3Q24 and R$68.7 million in 9M24, compared to adjusted net profits in 2023.

• Net financial expense was R$135.6 million in 3Q24, a 7% decrease year-over-year, reflecting lower interest rates and reduced net debt.

• Net debt at 3Q24 was R$2.11 billion, with leverage (ex-M&A) at 3.14x.

• Cash cycle improved to 50 days in 3Q24, 1 day better year-over-year and 19 days better sequentially.

Outlook and guidance

• Management expects further operational efficiency and profitability improvements from ongoing restructuring, supply chain, and cost reduction projects.

• SG&A savings targeted at R$10 million per month, with full impact expected by mid-2025.

• All distribution centers to have WMS implemented by 2025.

• Margin recovery anticipated as high-margin service operations normalize and new retail initiatives launch in 2025.